• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

Introduction to 2-(Difluoromethyl)-3,5-bis(trifluoromethyl)pyridine (CAS No. 1806300-73-1)

2-(Difluoromethyl)-3,5-bis(trifluoromethyl)pyridine, with the CAS number 1806300-73-1, is a highly specialized compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a pyridine ring substituted with difluoromethyl and trifluoromethyl groups. These functional groups contribute to the compound's exceptional chemical and biological properties, making it a valuable candidate for various applications in drug discovery and development.

The synthesis of 2-(Difluoromethyl)-3,5-bis(trifluoromethyl)pyridine has been extensively studied due to its potential as a building block in the synthesis of more complex molecules. Recent advancements in synthetic methodologies have enabled the efficient and scalable production of this compound, facilitating its broader application in both academic and industrial settings. One notable synthetic route involves the reaction of 2-chloro-3,5-bis(trifluoromethyl)pyridine with difluoromethyllithium, followed by deprotection steps to yield the final product.

In terms of its chemical properties, 2-(Difluoromethyl)-3,5-bis(trifluoromethyl)pyridine exhibits high stability under a variety of conditions. The presence of fluorine atoms significantly enhances its lipophilicity and metabolic stability, which are crucial factors in drug design. Additionally, the pyridine ring provides a platform for further functionalization, allowing for the introduction of additional pharmacophores to tailor the compound's biological activity.

The biological activity of 2-(Difluoromethyl)-3,5-bis(trifluoromethyl)pyridine has been explored in several preclinical studies. Research has shown that this compound possesses potent inhibitory effects on specific enzymes and receptors, making it a promising lead for the development of novel therapeutic agents. For instance, it has been reported to exhibit selective inhibition of certain kinases involved in cancer pathways, suggesting its potential as an anticancer agent. Furthermore, studies have also highlighted its activity against viral enzymes, indicating its potential utility in antiviral drug discovery.

One of the key challenges in the development of drugs based on 2-(Difluoromethyl)-3,5-bis(trifluoromethyl)pyridine is optimizing its pharmacokinetic properties. Recent research has focused on improving solubility and bioavailability through various prodrug strategies and formulation techniques. These efforts have led to the development of more effective drug candidates with enhanced therapeutic indices.

The environmental impact of 2-(Difluoromethyl)-3,5-bis(trifluoromethyl)pyridine is another important consideration in its use and development. Studies have shown that while the compound itself is stable and does not readily degrade in the environment, proper handling and disposal practices are essential to minimize any potential ecological risks. Green chemistry principles are increasingly being applied to the synthesis and use of this compound to ensure sustainability and environmental responsibility.

In conclusion, 2-(Difluoromethyl)-3,5-bis(trifluoromethyl)pyridine (CAS No. 1806300-73-1) represents a significant advancement in the field of medicinal chemistry. Its unique structural features and promising biological activities make it an attractive candidate for further research and development. As ongoing studies continue to uncover new applications and optimize its properties, this compound is poised to play a vital role in the discovery and development of innovative therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)